Hims & Hers, the high-flying telehealth company that rapidly ascended from a buzzy startup selling Viagra to a ...

Sure, the Cybertruck’s creator, Elon Musk, is a highly polarizing figure. But Christel Virag covered her vehicle in a pinky ...

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...

The Bartholomew County 4-H Fair opened its Friday schedule with a 4-H Rocket Demonstration north of the Grandstand.

Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper ...

Labrum is the founder of Meg Matters, a young nonprofit dedicated to suicide prevention and sharing mental health resources ...

Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers. Starting July 1, WeightWatchers will ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

If you discover a neighbor's dog trespassing in your garden, and you don't want them to, the first recommendation is to ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.